Promising Pathway Act

Take action

Contact your congresspeople about the Promising Pathway Act

Take legislative action

The Promising Pathway Act reintroduced in the Senate on May 13, 2021 will expedite beneficial outcomes for patients by requiring the Food and Drug Administration (FDA) to establish a rolling, real-time, priority review pathway for drugs intended to treat, prevent, or diagnose serious or life-threatening diseases or conditions.

Media Contact: Theresa Garner, theresa@iamals.org

Promising Pathway Act 2021 Updates

Promising Pathway Act 2020 Updates

We will find cures for ALS. The only question is when. That answer depends on you.

Stay informed on I AM ALS’ progress and what you can do to help us make hope real.

This field is required

Back to Top